Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Daniel Gomes Henriques"'
Autor:
Daniel Gomes Henriques, Elisa Baranski Lamback, Aline Helen da Silva Camacho, Monique Alvares Barbosa, Debora Aparecida Silva, Alexandro Guterres, Liana Lumi Ogino, Mônica R. Gadelha, Leila Chimelli, Leandro Kasuki, Carlos Henrique de Azeredo Lima
Publikováno v:
Endocrine. 72:208-215
Non-functioning pituitary adenomas (NFPA) are benign tumors, however, some are agressive. We aimed to assess if human telomerase reverse transcriptase (hTERT) is present in NFPA and if it can be used as a marker of aggressiveness and proliferation. C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::247a13c3a5534cc15a6ebbfd4b269448
https://doi.org/10.1007/s12020-020-02524-w
https://doi.org/10.1007/s12020-020-02524-w
Autor:
Olivia Faria, Daniel Gomes Henriques, Mônica R. Gadelha, Julio Abucham, Leila Chimelli, Luiz Eduardo Wildemberg, Lucio Vilar, Martha K.P. Huayllas, Leandro Kasuki, Margaret de Castro, Debora M. Nazato, Paula Conde Lamparelli Elias, Nina R. C. Musolino, Carlos Henrique de Azeredo Lima, Aline Helen da Silva Camacho, Jose Italo S Mota
Publikováno v:
Cancers
Volume 13
Issue 19
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Cancers, Vol 13, Iss 4857, p 4857 (2021)
Volume 13
Issue 19
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Cancers, Vol 13, Iss 4857, p 4857 (2021)
Background: It is still controversial if activating mutations in the stimulatory G-protein α subunit (gsp mutation) are a biomarker of response to first generation somatostatin receptor ligands (fg-SRL) treatment in acromegaly. Thus, we aimed to eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::059a9dbae455ce40a7557108c97a0c76
https://doi.org/10.3390/cancers13194857
https://doi.org/10.3390/cancers13194857
Autor:
Elisa Baranski Lamback, Debora Aparecida Silva, Mônica R. Gadelha, Leila Chimelli, Diego de Araujo Santos, Aline Helen da Silva Camacho, Carlos de Azeredo Lima, Daniel Gomes Henriques
Publikováno v:
Journal of the Endocrine Society
Introduction: Neuroendocrine tumors (NET) are uncommon, particularly when affecting the lungs having an incidence of 0.2 to 2 per 100,000. However, they represent 1-2% of all lung malignancies and up to 30% of all NET. In the context of Multiple Endo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be02cf63e18bced7f629049ddf3f7f2
https://doi.org/10.1210/js.2019-sun-322
https://doi.org/10.1210/js.2019-sun-322